5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
Evidence-based guide to dulaglutide dosing considerations for Black and African ancestry patients, including REWIND subgroup data, pharmacogenomic factors, and cardiorenal context.
Evidence-based guide to dulaglutide (Trulicity) dosing considerations for Hispanic and Latino patients, covering pharmacogenomics, metabolic phenotypes, and clinical trial subgroup data.
A clinical deep-dive into dulaglutide (Trulicity) dosing for East Asian patients, covering pharmacogenomics, BMI thresholds, ethnicity-stratified trial data, and practical dose-adjustment guidance prepared by the HealthRX.com Editorial Team.
Evidence-based review of dulaglutide (Trulicity) efficacy differences in Black and African ancestry populations, including REWIND subgroup data, pharmacogenomic factors, and dosing considerations.
A comprehensive clinical review of dulaglutide (Trulicity) safety, efficacy, and dosing considerations in South Asian patients, covering REWIND subgroup data, pharmacogenomics, and cardiovascular risk at lower BMI thresholds.